Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jan 16, 16:01
1167.10 -13.15 (-1.11%)
Volume
AVERAGE VOLUME
5-Day
15,253
10-Day
25,335
30-Day
23,438
13,331
  • Prev. Close

    1180.25

  • Open Price

    1171.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 16, 15:50
1172.70 -7.40 (-0.63%)
Volume
AVERAGE VOLUME
5-Day
807,805
10-Day
981,854
30-Day
802,605
909,022
  • Prev. Close

    1180.10

  • Open Price

    1174.20

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1172.70 (585)

Financials

Balance Sheet of Aurobindo Pharma (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
  12 mths 12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 29.20 29.15 29.12 29.11 29.11  
Total Share Capital 29.20 29.15 29.12 29.11 29.11  
Reserves and Surplus 5,330.34 3,983.24 2,909.98 2,464.06 2,540.50  
Total Reserves and Surplus 5,330.34 3,983.24 2,909.98 2,464.06 2,540.50  
Total Shareholders Funds 5,359.54 4,012.39 2,939.10 2,493.17 2,569.61  
NON-CURRENT LIABILITIES  
Long Term Borrowings 687.16 1,032.31 1,041.06 833.74 474.94  
Deferred Tax Liabilities [Net] 210.34 205.25 67.94 3.79 121.82  
Other Long Term Liabilities 0.00 0.00 0.00 0.00 0.00  
Long Term Provisions 22.65 8.30 8.50 4.12 3.10  
Total Non-Current Liabilities 920.15 1,245.86 1,117.50 841.65 599.86  
CURRENT LIABILITIES  
Short Term Borrowings 2,209.37 1,782.55 1,733.90 1,608.21 1,220.91  
Trade Payables 1,146.04 1,236.16 901.28 584.85 733.14  
Other Current Liabilities 504.76 192.39 68.04 405.78 663.33  
Short Term Provisions 86.02 106.18 64.75 57.55 54.32  
Total Current Liabilities 3,946.19 3,317.28 2,767.97 2,656.39 2,671.70  
Total Capital And Liabilities 10,225.88 8,575.53 6,824.57 5,991.21 5,841.17  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 2,190.01 1,937.94 2,011.91 1,626.65 1,349.72  
Intangible Assets 0.00 0.00 0.00 0.09 0.17  
Capital Work-In-Progress 227.19 0.00 0.00 0.00 0.00  
Other Assets 0.00 0.00 0.00 0.00 0.00  
Fixed Assets 2,417.20 2,141.83 2,178.25 2,184.82 1,886.62  
Non-Current Investments 993.11 872.59 707.94 610.32 493.04  
Deferred Tax Assets [Net] 0.00 0.00 0.00 0.00 0.00  
Long Term Loans And Advances 418.94 463.60 289.10 178.49 196.44  
Other Non-Current Assets 28.55 16.33 18.58 0.12 0.12  
Total Non-Current Assets 3,857.80 3,494.35 3,193.87 2,973.75 2,576.22  
CURRENT ASSETS  
Current Investments 19.64 0.03 0.04 18.68 0.04  
Inventories 2,145.05 1,711.81 1,431.73 1,219.26 1,261.02  
Trade Receivables 3,708.94 2,970.12 1,730.59 1,426.28 1,480.29  
Cash And Cash Equivalents 11.13 9.72 114.57 14.01 122.21  
Short Term Loans And Advances 400.85 314.73 275.98 262.48 375.08  
OtherCurrentAssets 82.47 74.77 77.79 76.75 26.31  
Total Current Assets 6,368.08 5,081.18 3,630.70 3,017.46 3,264.95  
Total Assets 10,225.88 8,575.53 6,824.57 5,991.21 5,841.17  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 0.00 0.00 0.00 0.00 0.00  
CIF VALUE OF IMPORTS  
Raw Materials 2,121.05 2,087.79 1,784.58 1,384.51 1,506.15  
Stores, Spares And Loose Tools 0.00 0.00 0.00 0.00 0.00  
Trade/Other Goods 0.00 0.00 0.00 0.00 0.00  
Capital Goods 121.08 38.82 34.91 73.04 82.74  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 205.69 164.43 116.64 361.33 63.26  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- -- -- -- --  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods 6,251.41 5,326.90 3,871.01 2,923.99 2,696.98  
Other Earnings 9.90 15.07 34.60 54.01 235.34  
BONUS DETAILS  
Bonus Equity Share Capital 17.35 17.35 17.35 17.35 17.35  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value -- -- -- -- --  
Non-Current Investments Unquoted Book Value 993.11 872.57 707.94 610.32 493.04  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value 0.03 0.03 0.04 0.05 0.07  
Current Investments Unquoted Book Value 19.61 -- -- 18.64 --  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347